MedPath

Development of the new prognostic markers for breast cancer patients based on immunoresponse monitoring

Not Applicable
Conditions
Breast cancer
Registration Number
JPRN-UMIN000029036
Lead Sponsor
Juntendo University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Female
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who didn't agree to participate in this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subset of lymphocytes is investigated using flow cytometry and the relationship with patient outcome will be analysed.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath